Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02562027 · ClinicalTrials.gov registry record · NA
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
NCT02562027: Completed NA study, sponsored by Washington University School of Medicine.
NCT02562027 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 217 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02562027, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
Study Summary
A principle objective of the study is to create a validated risk model for treatment selection. This will greatly enhance the ability to counsel patients regarding their specific risks/benefit ratio for surgery or SBRT. This will improve informed decision making on the part of the patient, and remove much of the subjectivity of treatment selection.
Primary Outcome
* Comorbidity scoring will be performed by interview and chart review including the Adult Comorbidity Evaluation 27 (ACE-27), Charlson Comorbidity Index (CCI), Global Initiative for Chronic Obstructive Lung Disease (GOLD), Cumulative Illness Rating Scale (CIRS), and COMorbidities in Chronic Obstructive Lung Disease (COMCOLD) * All of the comorbidity indices grade comorbidities from mild to severe. The investigators will use the data obtained from cumulative collected indices to determine the sev
Interventions
- BEHAVIORAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30
- BEHAVIORAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13
- BEHAVIORAL Modified Medical Research Council
- BEHAVIORAL EQ-5D
- BEHAVIORAL Center for Epidemiological Studies Depression Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2015-09-11 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
What the finished NCT02562027 record still lists
NCT02562027 is an interventional study that assigns participants to a tested intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 5 interventions - of which European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 is the first listed.
NCT02562027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02562027 about?
NCT02562027 is a clinical study titled "SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer". A principle objective of the study is to create a validated risk model for treatment selection. This will greatly enhance the ability to counsel patients regarding their specific risks/benefit ratio for surgery or SBRT. This will improve informed decision making on the part of the patient, and remov...
What is the current status of trial NCT02562027?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2015-09-11. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT02562027?
The interventions under investigation include: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (BEHAVIORAL), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13 (BEHAVIORAL), Modified Medical Research Council (BEHAVIORAL), EQ-5D (BEHAVIORAL), Center for Epidemiological Studies Depression Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT02562027?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02562027's enrollment target sits among peer trials
217 485th of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI